Abstract
Introduction: Hypocretin-1 is a hypothalamic neuropeptide that may help regulate arousal and feeding behavior and is quantifiable in cerebrospinal fluid (CSF). In this retrospective pilot study, hypocretin-1 levels obtained from ventricular CSF of neurologically injured patients were correlated with clinical and laboratory results to test whether arousal or metabolic factors might be related to the level of hypocretin-1.
Methods: CSF samples from a heterogeneous group of neurosurgical patients with externally draining intraventricular catheters were assayed in a standard manner for hypocretin-1 and other routine laboratories. Associations were sought between hypocretin-1 and clinical data such as body mass index (BMI), temperature, and Glasgow Coma Scale (GCS) score and between hypocretin-1 and laboratory data such as serum and CSF glucose, protein, and cell counts.
Results: Lower levels of ventricular CSF hypocretin-1 were correlated with higher levels of serum (p=0.020) and ventricular CSF glucose (p=0.001). Clinical findings such as BMI, temperature, and GCS failed to correlate with hypocretin-1.
Conclusions: In a group of neurologically injured patients, hypocretin-1 and glucose levels are inversely correlated. More studies are needed to investigate these associations, particularly in a homogenous patient sample.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998;95:322–327.
Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573–585.
Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39–40.
Moriguchi T, Sakurai T, Nambu T, Yanagisawa M, Goto K. Neurons containing orexin in the lateral hypothalamic area of the adult rat brain are activated by insulin-induced acute hypoglycemia. Neurosci Lett 1999;264:101–104.
Willie JT, Chemilli RM, Sinton CM, Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 2001;24:429–458.
Husain AM, Yancy WS Jr, Carwile ST, Miller PP, Westman EC. Diet therapy for narcolepsy. Neurology 2004;62:2300–2302.
Bruck D, Armstrong S, Coleman G. Sleepiness after glucose in narcolepsy. J Sleep Res 1994;3:171–179.
Ripley B, Overeem S, Fujiki N, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology 2001;57:2253–2258.
Claassen J, Vu A, Kreiter KT, Kowalski RG, et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med 2004;32:832–838.
Gray CS, Hildreth AJ, Alberti GK, O’Connell JE; GIST Collaboration. Poststroke hyperglycemia: natural history and immediate management. Stroke 2004;35:122–126.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Doherty, M.J., Watson, N.F., Hallam, D.K. et al. Ventricular cerebrospinal fluid hypocretin-I inversely correlates with glucose levels in cerebrospinal fluid and serum from patients with neurological injuries. Neurocrit Care 3, 230–233 (2005). https://doi.org/10.1385/NCC:3:3:230
Issue Date:
DOI: https://doi.org/10.1385/NCC:3:3:230